Q4 EPS Estimates for Abacus Life Lifted by Northland Capmk

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Stock analysts at Northland Capmk raised their Q4 2025 earnings per share estimates for Abacus Life in a research note issued on Friday, May 9th. Northland Capmk analyst M. Grondahl now anticipates that the company will post earnings per share of $0.28 for the quarter, up from their previous estimate of $0.27. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share.

ABL has been the subject of several other research reports. Piper Sandler increased their target price on shares of Abacus Life from $11.50 to $12.00 and gave the company an "overweight" rating in a research note on Friday. Maxim Group started coverage on shares of Abacus Life in a research note on Tuesday, April 29th. They issued a "buy" rating and a $14.00 target price for the company. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $14.08.

Abacus Life Stock Up 5.4%

NASDAQ ABL opened at $8.83 on Monday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a 50-day simple moving average of $7.73 and a 200 day simple moving average of $7.84. Abacus Life has a twelve month low of $6.34 and a twelve month high of $12.40. The stock has a market cap of $855.21 million, a PE ratio of -49.05 and a beta of 0.14.

Abacus Life (NASDAQ:ABL - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.02. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The company had revenue of $44.14 million for the quarter, compared to the consensus estimate of $39.51 million.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. raised its stake in shares of Abacus Life by 152.2% in the first quarter. Charles Schwab Investment Management Inc. now owns 154,700 shares of the company's stock valued at $1,159,000 after acquiring an additional 93,348 shares during the last quarter. Pacific Ridge Capital Partners LLC bought a new position in shares of Abacus Life in the first quarter valued at approximately $358,000. Bastion Asset Management Inc. bought a new position in shares of Abacus Life in the first quarter valued at approximately $4,353,000. Royce & Associates LP raised its stake in shares of Abacus Life by 39.6% in the first quarter. Royce & Associates LP now owns 1,824,253 shares of the company's stock valued at $13,664,000 after acquiring an additional 517,822 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Abacus Life in the first quarter valued at approximately $249,000.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.